Question Bank › The hard part is already done

The hard part is already done

The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col

Calls Tested
496
Answered YES
14
Hit Rate
2.8%
rare by design

Akebia Therapeutics, Inc. (AKBA) — this company's answers

NO on the Q3 2021 call 2021-11-09 C+
The model's full reasoning — Q3 2021 call → NOWe need to answer YES or NO based on the transcript. The question asks: Does management convey that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking, and has now entered the phase where the company collects on that completed work, with reported results still mostly reflecting the paying phase rather than the collecting phase? We need to look for evidence in the transcript. The company is Akebia, developing vadadustat for anemia due to CKD. The PDUFA date is March 2022. They have completed Phase 3 trials, submitted NDA, and are awaiting approval. They have also launched in Japan via partner, and submitted MAA in Europe. They are preparing for launch. Key points: They have completed the heavy phase of clinical development. The collaboration revenue is down because vadadustat related expenses have tapered. They are now in pre-commercialization. They have a commercial team in place. They are expecting milestones upon approval. But approval is not yet obtained. The payoff (revenue from vadadustat) is not yet begun. They are still in the pre-launch phase. The heavy phase (clinical trials) is done, but the collecting phase (revenue from vadadustat) has not begun. They have Auryxia revenue, but that's a separate product. The question is about a major undertaking: the development of vadadustat. The heavy phase (R&D) is complete. The collecting phase (launch) is not yet begun; it's contingent on FDA approval. The transcript says "vadadustat is not yet approved." So the payoff is only projected, not yet arrived. The question says: "Answer NO if the payoff is only promised, projected, or contingent, with nothing yet begun to arrive." That seems to be the case. They have not yet received approval, so no revenue from vadadustat. They have milestones that are contingent on approval. So the collecting phase has not visibly begun. The heavy phase is done, but the return is not yet beginning. The reported results still reflect the paying phase (R&D costs) but also Auryxia revenue. However, the question is about the major undertaking of vadadustat. The heavy phase is done, but the collecting phase hasn't started. So the answer is NO. But let's check if there is any indication that they are already collecting.

← Back to the full AKBA analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company has RECENTLY FINISHED THE EXPENSIVE, UNCERTAIN, OR HEAVY PHASE OF A MAJOR UNDERTAKING \u2014 the part that consumed money, time, and organizational energy \u2014 and has now entered the phase where the company COLLECTS on that completed work, with the reported results still mostly reflecting the paying phase rather than the collecting phase? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation with both halves present as a present-tense reality: (1) THE HEAVY PHASE IS DESCRIBED AS SUBSTANTIALLY DONE. Management indicates that the demanding part of a significant undertaking \u2014 a build, expansion, development program, product creation, ramp-up, integration, turnaround, transition, certification effort, or market entry \u2014 has been completed or has clearly peaked and is winding down. Management describes the major costs, risks, or unknowns in the past tense: built, completed, finished, behind us, largely done, peaked, de-risked. This must be grounded in real accomplished work, not in a plan to finish. (2) THE COLLECTING PHASE HAS VISIBLY BEGUN BUT IS ONLY EARLY IN THE NUMBERS. Management conveys that the benefit of that completed effort is now starting to arrive \u2014 first revenues, first shipments, initial customers or volumes, spending that is now falling away while activity holds or grows, margins or cash beginning to turn, or committed business now flowing against the already-built base \u2014 while making clear, directly or plainly in substance, that the results just reported still carry the burden of the effort and reflect little of its return, so the coming quarters mechanically look different from the reported one as the benefit phases in. The undertaking, the form of its cost, and the form of its payoff may vary widely across industries. What matters is the LIFECYCLE POSITION management describes: the expensive uncertainty is behind, the return is beginning, and the published numbers lag the crossing. Answer NO if the company is still in the middle of its heavy phase, with major spending, risk, or completion still ahead. NO if the payoff is only promised, projected, or contingent, with nothing yet begun to arrive. NO if the completed effort was routine in scale for this company \u2014 ordinary maintenance, a normal product refresh, an ordinary store-opening cadence \u2014 rather than a significant undertaking relative to the company's size. NO if the benefit is already substantially reflected in the reported results, leaving no meaningful lag between the crossing and the numbers. NO if management is chiefly explaining delays, overruns, or failures of the undertaking. NO if the improvement described depends mainly on outside conditions recovering \u2014 prices, demand, macro \u2014 rather than on the company's own completed effort now paying. NO if the crossing appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
HUYA HUYA Inc. Q4 2023 2024-03-19 C
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
AKYA Akoya Biosciences, Inc. Q2 2023 2023-08-07 C+
AFL Aflac Incorporated Q2 2023 2023-08-02 C+
DAL Delta Air Lines, Inc. Q2 2023 2023-07-13 A
CURV Torrid Holdings Inc. Q2 2022 2022-09-07 D
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
OOMA Ooma, Inc. Q3 2022 2021-12-02 B+
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
WES Western Midstream Partners, LP Q3 2018 2018-10-31 D
HTLF Heartland Financial USA, Inc. Q3 2017 2017-10-30 B+
IBTX Independent Bank Group, Inc. Q3 2017 2017-10-24 A
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
ARCB ArcBest Corporation Q4 2016 2017-02-08 C

How the model reasoned

IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.

More from the question bank

Sold out of itselfFront, middle, and back of the business all Young streak off a low baseSizing the constraint out loudStill getting better as they speakProven engine, fuel already in the tankAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.